Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Andreu

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cancers|December 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL StudyPau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, et al.
British Journal of Cancer|October 1, 2025
Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemiaJosé Vicente Gil, Gayane Avetisyan, Alberto Miralles, et al.
Cancer|July 1, 2011
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndromeIris Cordoba, José R González-Porras, Benet Nomdedeu, et al.
Leukemia Research|May 6, 2014
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemiaRegina García-Delgado, Dunia de Miguel, Alicia Bailén, et al.
Journal of Medical Virology|July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept studyCarlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Transplantation and Cellular Therapy|March 30, 2021
Central Nervous System Involvement in Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell TransplantationAitana Balaguer-Rosello, José Luis Piñana, Luis Bataller, et al.
Haematologica|October 24, 2008
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO studyAlejandro Martín, Eulogio Conde, Montserrat Arnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
Haematologica|March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemiaDaniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
Leukemia Research|December 10, 2014
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk scoreJose Falantes, Regina García Delgado, Cristina Calderón-Cabrera, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancers|December 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL StudyPau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, et al.
British Journal of Cancer|October 1, 2025
Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemiaJosé Vicente Gil, Gayane Avetisyan, Alberto Miralles, et al.
Cancer|July 1, 2011
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndromeIris Cordoba, José R González-Porras, Benet Nomdedeu, et al.
Leukemia Research|May 6, 2014
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemiaRegina García-Delgado, Dunia de Miguel, Alicia Bailén, et al.
Journal of Medical Virology|July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept studyCarlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Transplantation and Cellular Therapy|March 30, 2021
Central Nervous System Involvement in Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell TransplantationAitana Balaguer-Rosello, José Luis Piñana, Luis Bataller, et al.
Haematologica|October 24, 2008
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO studyAlejandro Martín, Eulogio Conde, Montserrat Arnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic SyndromesLeonor Arenillas, Xavier Calvo, Elisa Luño, et al.
Haematologica|March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemiaDaniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
Leukemia Research|December 10, 2014
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk scoreJose Falantes, Regina García Delgado, Cristina Calderón-Cabrera, et al.
Pageof 5